Skip to main content
InVivo suspends enrollment in Neuro-Spinal Scaffold trial

InVivo Therapeutics has suspended enrollment in a trial evaluating its Neuro-Spinal Scaffold for treatment of complete thoracic AIS A spinal-cord injury, after the study recorded three patient deaths. InVivo said the deaths were not related to the implantation procedure or the device, but company leaders will work with the FDA to determine whether enrollment criteria should be revised.

Full Story: